The Nefarious Nexus of Noncoding RNAs in Cancer

Eleni Anastasiadou1, Alberto Faggioni2, Pankaj Trivedi3

  • 1HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Eanasta1@bidmc.harvard.edu.

Insights

Noncoding RNAs (ncRNAs) are now recognized as crucial functional molecules impacting biological processes and disease. Understanding ncRNA networks is key to developing novel cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Noncoding RNAs (ncRNAs) have transitioned from "dark matter" to critical functional molecules.
  • ncRNAs influence numerous physiological processes in both development and disease.
  • ncRNA networks play a significant role in regulating cellular transcriptome and proteome.

Purpose of the Study:

  • To highlight the growing importance of ncRNAs in cancer.
  • To emphasize the need for understanding ncRNA regulatory networks.
  • To explore the potential of ncRNAs in developing new cancer therapies.

Main Methods:

  • Review of recent advancements in ncRNA research.
  • Analysis of ncRNA interactions and network formation.
  • Exploration of regulatory mechanisms governing ncRNAs.

Main Results:

  • ncRNAs are integral to cellular regulation and biological outcomes.
  • ncRNA regulatory circuits are increasingly implicated in cancer development.
  • Complex ncRNA interactions offer insights into disease mechanisms.

Conclusions:

  • Further investigation into ncRNA networks and regulation is crucial.
  • Understanding ncRNA complexity can lead to improved cancer treatment strategies.
  • ncRNAs represent a promising frontier for oncological therapeutics.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.7K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.7K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.6K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K